P

Inventor

ZHANG GUOLIANG

CN29 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG GUOLIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BEIGENE LTD

15 patents
US9670203B2Jun 6, 2017

Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors

BEIGENE LTD4 citations84
US10864203B2Dec 15, 2020

Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer

BEIGENE LTD10 citations83
US10647714B2May 12, 2020

5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenases

BEIGENE LTD2 citations73
US10562899B2Feb 18, 2020

Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors

BEIGENE LTD1 citations73
US10351559B2Jul 16, 2019

Maleate salts of a B-RAF kinase inhibitor, crystalline forms, methods of preparation, and uses therefore

BEIGENE LTD2 citations73
US10280163B2May 7, 2019

5 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenases

BEIGENE LTD5 citations73
US10208038B2Feb 19, 2019

Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors

BEIGENE LTD2 citations73
US9920055B2Mar 20, 2018

Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors

BEIGENE LTD3 citations73
US10576087B2Mar 3, 2020

Fused tricyclic compounds as Raf kinase inhibitors

BEIGENE LTD2 citations72
US9895376B2Feb 20, 2018

Fused tricyclic compounds as Raf kinase inhibitors

BEIGENE LTD3 citations72
US11534431B2Dec 27, 2022

Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer

BEIGENE LTD1 citations62
US10882856B2Jan 5, 2021

5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases

BEIGENE LTD1 citations62
US12582604B2Mar 24, 2026

Stable solid dispersion of a B-RAF kinase dimer inhibitor, methods of preparation, and uses therefor

BEIGENE LTD0 citations56
US11472811B2Oct 18, 2022

Pyrazolotriazolopyrimidine derivatives as A2A receptor antagonist

BEIGENE LTD0 citations52
US12281119B2Apr 22, 2025

Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist

BEIGENE LTD0 citations48

SAMSUNG ELECTRONICS CO LTD

2 patents

ZHOU CHANGYOU

1 patent

VEPCO TECH

1 patent

BEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD

1 patent

WANG WENLIN

1 patent

3M INNOVATIVE PROPERTIES COMPANY

1 patent

MICRON OPTOELECTRONICS CO LTD

1 patent

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD

1 patent

UNIV SOUTHWEST PETROLEUM

1 patent

TIANJIN MUNICIPAL ENGINEERING DESIGN & RES INSTITUTE CO LTD

1 patent

BeOne Medicines | GmbH

1 patent

JIANGSU HENGLI HYDRAULIC CO LTD

1 patent

SONG HUICHENG

1 patent